Citigroup
ONCY

Citigroup’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Citigroup’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-184
Closed – – 8241
2015
Q3 		$0 Sell
184
-1,477
-89% -$845 ﹤0.01% 8171
2015
Q2 		$1K Sell
1,661
-4,303
-72% -$2.92K ﹤0.01% 7455
2015
Q1 		$4K Buy
5,964
+5,727
+2,416% +$3.68K ﹤0.01% 6838
2014
Q4 		$0 Buy
+237
New +$143 ﹤0.01% 7531
2014
Q3 		– Sell
-172
Closed – – 7513
2014
Q2 		$0 Sell
172
-2,198
-93% -$3.15K ﹤0.01% 7519
2014
Q1 		$4K Buy
2,370
+1,040
+78% +$1.76K ﹤0.01% 6674
2013
Q4 		$2K Buy
1,330
+1,296
+3,812% +$2.92K ﹤0.01% 6816
2013
Q3 		$0 Hold
34
– – ﹤0.01% 7164
2013
Q2 		$0 Buy
+34
New +$94 ﹤0.01% 6862

Other funds holding ONCY

NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
KWMG
King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return
CS
Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Citigroup's ONCY Position: Q4 2015 in Review

Citigroup sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 184 shares.

Citigroup first reported a position in ONCY in Q2 2013 and held it in 9 quarters. The position peaked at $4K in Q1 2015. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Citigroup reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Citigroup sold 184 ONCOLYTICS BIOTECH INC shares in Q4 2015.
  • Citigroup first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 9 quarters.
  • Citigroup's ONCOLYTICS BIOTECH INC position peaked at $4K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Citigroup's 13F filing for Q4 2015, filed 12 Feb 2016.